Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial

Kaper, Janneke; Wagena, Edwin J.; Willemsen, Marc C.; Schayck, C.P. van

doi:10.1111/j.1360-0443.2005.01097.x

Cited by 83 publications

(76 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Au et al 25 showed within a cohort study of 23,971 current and past smokers that smoking cessation was associated with a reduced risk of exacerbations. Reimbursing the costs of smoking cessation therapy has been shown to be both efficacious 26 and cost-effective. 27 Exacerbations are important determinants of prognosis in patients with COPD, and are associated with economic costs, 28 health status, 29,30 lung function, 31 and mortality.…”

Section: Discussionmentioning

confidence: 99%

Disease Management Programs for Patients With COPD in Germany: A Longitudinal Evaluation of Routinely Collected Patient Records

et al. 2013

View full text Add to dashboard Cite

INTRODUCTION:The primary aim of the disease management program (DMP) for patients with COPD is to improve health outcomes and thereby to reduce overall costs. Six years after its introduction in Germany, no consensus has yet been reached as to whether the DMP has been effective in reaching these goals. The objective of the study was an evaluation of the DMP for COPD in Bavaria using routinely collected subject medical records. METHODS: A longitudinal population-based study, comparing the total DMP population of up to 86,560 patients with a stable cohort of 17,549 subjects over a period of 5 years. The effect of subject dropout in the cohort is further estimated by means of inverse probability weighting. RESULTS: The proportion of subjects in the total population who were prescribed and received treatment with oral corticosteroids declined at a constant rate of 1.0% per year (P < .001). The proportion of subjects who were given a prescription for theophylline decreased at a constant rate of 2.0% per year (P < .001). By 2012, 15.6% of the total population and 26% of the cohort had undergone self-management education. While the proportion of smokers in the total population remained constant because of the effect of newly enrolled subjects, the proportion of smokers decreased significantly even after dropout adjustment, from 29% to 21%. The occurrence of exacerbations decreased steadily at a rate of 0.9% (total population) or 0.7% (cohort) per year. While the occurrence of emergency hospital admissions decreased in the total population, an increase was observed within the cohort. CONCLUSIONS: Summarizing all results leads to the suggestion that the German DMP for COPD has been effective in enhancing the quality of care in regard to an improved adherence to guidelines, pharmacotherapy, exacerbations, and self-management education. However, the DMP was not able to prevent an increase in emergency hospital admissions for the stable population in the cohort.

show abstract

Section: Discussionmentioning

confidence: 99%

Disease Management Programs for Patients With COPD in Germany: A Longitudinal Evaluation of Routinely Collected Patient Records

et al. 2013

View full text Add to dashboard Cite

show abstract

“…It is important to start smoking cessation as early as possible as patients with COPD stop smoking less easily than smokers without COPD. Reimbursement of smoking cessation treatment clearly increases smoking cessation rates [62].…”

Section: Smoking Cessation In Copdmentioning

confidence: 99%

Tobacco use in relation to COPD and asthma: Fig. 1—

Hylkema¹,

Sterk²,

Boer³

et al. 2007

Eur Respir J

View full text Add to dashboard Cite

Smoking is the leading cause of preventable death worldwide. Hundreds of millions of individuals still smoke, affecting their health as well as that of their peers, family and offspring. Smoking is a well-established prime risk factor for chronic obstructive pulmonary disease and hampers the response to treatment in asthma and chronic obstructive pulmonary disease. In the present paper, new concepts are discussed with respect to pathology, treatment, smoking cessation and tobacco control. Recommendations for future directions are given.

show abstract

“…This assumption is problematic if it is not correct, as it could potentially bias results and statistical tests in favour of an effective treatment if attrition rates are higher in the control group. Also, there is some evidence to suggest that those lost to follow-up may not necessarily be smoking [25][26][27][28][29] .…”

Section: Downloaded Frommentioning

confidence: 99%

An Exploratory Analysis of the Smoking and Physical Activity Outcomes From a Pilot Randomized Controlled Trial of an Exercise Assisted Reduction to Stop Smoking Intervention in Disadvantaged Groups

Thompson¹,

Greaves²,

Ayres³

et al. 2015

NICTOB

View full text Add to dashboard Cite

Reimbursement for smoking cessation treatment may double the abstinence rate: results of a randomized trial

Abstract: Reimbursement for SCT seems efficacious in increasing the use of SCT and may double the number of successful quitters.

Cited by 83 publications

References 19 publications

Disease Management Programs for Patients With COPD in Germany: A Longitudinal Evaluation of Routinely Collected Patient Records

Disease Management Programs for Patients With COPD in Germany: A Longitudinal Evaluation of Routinely Collected Patient Records

Tobacco use in relation to COPD and asthma: Fig. 1—

An Exploratory Analysis of the Smoking and Physical Activity Outcomes From a Pilot Randomized Controlled Trial of an Exercise Assisted Reduction to Stop Smoking Intervention in Disadvantaged Groups

Contact Info

Product

Resources

About